FBM30 1632.47
+0.87points (+0.05%) Volume 1,354mil Value 1,863.5mil
1) KLCI recovered from its low of 1626.68 (-4.92pts) as
weaker China PMI of 50.1 in July was offset by China government's pledge to
maintain economic expansion. Investors sentiment will remain cautious as they
await for any stimulus from the ECB meeting on Aug 2. Consumer names generated
buying interest led by PWROOT+7%, PADINI+6% and OLDTOWN+5.3%. Market breadth was positive with advancers edging losers
383:375. Futures closed 1633.5pts (1.03points premium).
2) Heavyweights: UMW+3.48% RM9.80, AXIATA+0.5% RM5.89,
MAYBANK+0.34% RM8.79, CIMB+0.38% RM7.88, TENAGA+0.59% RM6.79, TM+1.06% RM5.71,
GENTING-1.58% RM9.32, YTL-2.15% RM1.82
3) DBT: INGENS 11.6mil @ RM0.12 (2.1% PUC), FGV 5.9mil @
RM5.12
4) Situationals:
GKENT+4.85% RM1.08: GKENT-Lion Pacific Sdn Bhd consortium
(GKM) has been awarded the Ampang line extension project valued at
RM955.84mil. GKM is further awarded the supply of Train Borne Equipment
together with Works in respect of which Prasarana has Options which it can
exercise together for a total of RM128.6mil. The contract entails the
engineering, procurement, construction, testing and commissioning of the
Signalling System, Communication, Trackwork and 3rd Rail, Electrification of
the Rail System and other associated works for the Ampang LRT Line to be
extended by another 17.7km, connecting the current Sri Petaling station to
Putra Heights. The contract is expected to commence immediately and the
completion period is 44months from the date of the LOA.
NAIM+3.95% RM1.84: Naim Engineering Sdn Bhd has received
a RM208 million contract from Mass Rapid Transit Corporation Sdn Bhd for
the works packages under the Klang Valley Mass Rapid Transit (MRT) project.
NAIM will undertake package S4 under the Sungai Buloh-Kajang MRT alignment,
which involves the construction of elevated stations and related works at Section
16, Pusat Bandar Damansara and Semantan.
5) KPJ Healthcare: Co announced that it's wholly owned
subsidiary Kump Perubatan Johor SB has entered into a Share Sale Agreement with
Sabah Medical Centre for the acquisition of the balance of 49% in SMC Healthcare
SB(SMCH) for a cash consideration of RM54.88m. With the completion of the
acquisition, SMCH shall be a wholly owned subsidiary. The purchase
consideration shall be financed from internally generated funds of the KPJ
group; +ve on acquisition, in line with group's strategy to add on 2 hospital
pa to meet the growing healthcare demand, enlarge the customer base &
further establish itself as a key healthcare service provider in Malaysia.
Group on track to meet 3-year EPS CAGR of 20% from FY12-FY15. Currently trading
at about 15% discount to regional peers - BOW.
6) Mkt: continue its range trade while markets await for
decisions on monetary policy from the FOMC & ECB. Buy IJM on potential of
positive news from the West Coast Expressway(WCE) project as indicated by the
price & volume action of Kumpulun Europlus (KEUR MK). IJM has a 20% stake
in WCE concession with KEUR controlling the balance 80%.